Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer
2012 · Cell Reports · 133 citations
https://doi.org/10.1016/j.celrep.2012.06.017
É
Étienne Chatelut
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
347
Papers
9.0K
Citations
51
h-index
160
i10-index
Étienne Chatelut is an academic researcher from Université Toulouse III - Paul Sabatier. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Chemotherapy-induced organ toxicity mitigation & Cancer therapeutics and mechanisms. The author has an h-index of 51, co-authored 295 publications.
ORCID: 0000-0002-7740-9096Papers by this author
worksTherapeutic drug monitoring in cancer – Are we missing a trick?
2014 · European Journal of Cancer · 100 citations
https://doi.org/10.1016/j.ejca.2014.04.013
Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents
2012 · British Journal of Cancer · 88 citations
https://doi.org/10.1038/bjc.2012.357
Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma
2005 · Annals of Oncology · 50 citations
https://doi.org/10.1093/annonc/mdi405
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda®) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours
2005 · British Journal of Cancer · 25 citations
https://doi.org/10.1038/sj.bjc.6602354
Comparing ultrafiltration and equilibrium dialysis to measure unbound plasma dolutegravir concentrations based on a design of experiment approach
2020 · Scientific Reports · 16 citations
https://doi.org/10.1038/s41598-020-69102-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat